Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
3.940
+0.040 (1.03%)
Last updated: Jul 17, 2025
27.92%
Market Cap27.46M
Revenue (ttm)67.37M
Net Income (ttm)253.45K
Shares Out7.04M
EPS (ttm)n/a
PE Ratio108.34
Forward PE7.22
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume3,228
Open3.940
Previous Close3.900
Day's Range3.940 - 3.940
52-Week Range1.860 - 3.960
Beta0.18
RSI68.18
Earnings Daten/a

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized, and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments and manufacturing services. Labi... [Read more]

Sector Healthcare
Founded 1958
Employees 369
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.